- Less Knee Osteoarthritis if take more Vitamin D – 8 MRI confirmations – Nov 2018
- Knee Osteoarthritis benefited by 20 ng of Vitamin D for 5 years – RCT July 2018
- Knee osteoarthritis helped by vitamin D2 (40,000 IU weekly raised 57 % above 30 ng) June 2017
- Reduced knee osteoarthritis if consistently supplement with vitamin D for 2 years – April 2017
- Knee pain in seniors predicted by low vitamin D 5 years before – Feb 2014
- Knee Osteoarthritis (Radiographic ) 3X less if have lots of Magnesium – May 2015
- Personal note by Founder of VitaminDWiki: I was suddenly unable to walk 1000 feet without severe pain in my right knee. I was diagnosed as having Knee Osteoarthritis (while having had a high level of vitamin D for years). I applied topical Magnesium Chloride to my knee nightly for about a month and took MgCl internally - the knee pain totally went away.
Osteoarthritis category includes the following
Overview Osteoarthritis and Vitamin D
Search VitaminDWiki for CARTILAGE 393 items as of July 2018
See also Ankylosing spondylitis
Rheumatic Diseases often treated by Vitamin D, may need 40-60 ng – Oct 2021
Knee osteoarthritis: Vitamin D is the 4th best treatment – meta-analysis Oct 2020
Vitamin D in the Prevention and Treatment of Osteoarthritis: From Clinical Interventions to Cellular Evidence - Jan 2019
Nutrients. 2019 Jan 22;11(2). pii: E243. doi: 10.3390/nu11020243.
Older adults are recommended vitamin D to prevent fractures. Though this population is also at risk of osteoarthritis (OA), the effect of vitamin D on OA is unclear and may differ by disease state. The relationship between vitamin D and OA during OA initiation and progression were considered in this narrative review of in vivo and in vitro studies. Regarding OA initiation in humans, the small number of published observational studies suggest a lack of association between induction of OA and vitamin D status. Most randomized controlled trials were performed in White OA patients with relatively high vitamin D status (>50 nmol/L). These studies found no benefit of vitamin D supplementation on OA progression. However, subset analyses and one randomized controlled pilot trial indicated that vitamin D supplementation may alleviate joint pain in OA patients with low vitamin D status (<50 nmol/L). As the etiology of OA is recently being more fully uncovered, better animal and cell models are needed. According to currently available clinical results, evidence is lacking to set a vitamin D level to prevent OA, and increasing vitamin D status above 50 nmol/L does not seem to benefit OA patients.
Vitamin D supplementation and inflammatory and metabolic biomarkers in patients with knee osteoarthritis: post hoc analysis of a randomised controlled trial.
Br J Nutr. 2018 Jul;120(1):41-48. doi: 10.1017/S0007114518001174.
Zheng S1, Wang B2, Han W1, Zhu Z1, Wang X1, Jin X1, Antony B1, Cicuttini F2, Wluka A2, Winzenberg T1, Aitken D1, Blizzard L1, Jones G1, Ding C1.
1 Menzies Institute for Medical Research,University of Tasmania,Hobart,TAS,Australia.
2 Department of Epidemiology and Preventive Medicine,Monash University,VIC,Australia.
Erratum in: Vitamin D supplementation and inflammatory and metabolic biomarkers in patients with knee osteoarthritis: post hoc analysis of a randomised controlled trial - Corrigendum. [Br J Nutr. 2019]
Download the PDF from VitaminDWiki
The aim of this study was to determine whether vitamin D supplementation and maintaining vitamin D sufficiency are associated with changes in inflammatory and metabolic biomarkers in patients with knee osteoarthritis (OA) and vitamin D deficiency. A total of 413 participants with symptomatic knee OA and vitamin D deficiency were enrolled in a randomised, placebo-controlled trial and received 1·25 mg vitamin D3 or placebo monthly for 24 months across two sites. In this post hoc analysis, 200 participants from one site (ninety-four from the placebo group and 106 from the vitamin D group; mean age 63·1 (sd 7·3) years, 53·3 % women) were randomly selected for measurement of serum levels of inflammatory and metabolic biomarkers at baseline and 24 months using immunoassays. In addition, participants were classified into two groups according to serum 25-hydroxyvitamin D (25(OH)D) levels at months 3 and 24: (1) not consistently sufficient (25(OH)D≤50 nmol/l at either month 3 or 24, n 61), and (2) consistently sufficient (25(OH)D>50 nmol/l at both months 3 and 24, n 139). Compared with placebo, vitamin D supplementation had no significant effect on change in serum high-sensitive C-reactive protein, IL-6, IL-8, IL-10, leptin, adiponectin, resistin, adipsin and apelin. Being consistently vitamin D sufficient over 2 years was also not associated with changes in these biomarkers compared with not being consistently sufficient. Vitamin D supplementation and maintaining vitamin D sufficiency did not alter serum levels of inflammatory and metabolic biomarkers over 2 years in knee OA patients who were vitamin D insufficient, suggesting that they may not affect systemic inflammation in knee OA patients.Title was revised Sept 2019 which caused the visitor count to reset.
There have actually been
|2377 visitors, last modified 07 Sep, 2019,